Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Asano

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|June 23, 2007
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipientsKumi Oshima, Yoshinobu Kanda, Yuki Asano-Mori, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in JapanSaiko Kurosawa, Ayako Mori, Mayumi Tsukagoshi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Transplantation and Cellular Therapy|May 29, 2026
Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid LeukemiaKyosuke Yamaguchi, Otoya Watanabe, Takashi Mitsuki, et al.
International Journal of Hematology|March 6, 2008
Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantationYuki Asano-Mori, Yoshinobu Kanda, Kumi Oshima, et al.
Leukemia Research|February 6, 2026
Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCTTomoyo Kubo, Hisashi Yamamoto, Otoya Watanabe, et al.
Transplantation and Cellular Therapy|September 10, 2025
Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid MalignanciesJotaro Yamamoto, Hisashi Yamamoto, Mika Kuno, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 1, 2026
CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma in a nonagenarian patientJotaro Yamamoto, Daisuke Kaji, Mika Kuno, et al.
Annals of Hematology|April 27, 2026
Differential impact of allogeneic stem-cell transplantation on large B-cell lymphomas and peripheral T-cell lymphomasFutoshi Yoshino, Daisuke Kaji, Mika Kuno, et al.
International Journal of Hematology|March 19, 2026
Cord blood versus matched related donor transplantation in AML not in remission: role of pre-engraftment immune reactionsTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|June 23, 2007
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipientsKumi Oshima, Yoshinobu Kanda, Yuki Asano-Mori, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in JapanSaiko Kurosawa, Ayako Mori, Mayumi Tsukagoshi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Transplantation and Cellular Therapy|May 29, 2026
Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid LeukemiaKyosuke Yamaguchi, Otoya Watanabe, Takashi Mitsuki, et al.
International Journal of Hematology|March 6, 2008
Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantationYuki Asano-Mori, Yoshinobu Kanda, Kumi Oshima, et al.
Leukemia Research|February 6, 2026
Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCTTomoyo Kubo, Hisashi Yamamoto, Otoya Watanabe, et al.
Transplantation and Cellular Therapy|September 10, 2025
Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid MalignanciesJotaro Yamamoto, Hisashi Yamamoto, Mika Kuno, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 1, 2026
CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma in a nonagenarian patientJotaro Yamamoto, Daisuke Kaji, Mika Kuno, et al.
Annals of Hematology|April 27, 2026
Differential impact of allogeneic stem-cell transplantation on large B-cell lymphomas and peripheral T-cell lymphomasFutoshi Yoshino, Daisuke Kaji, Mika Kuno, et al.
International Journal of Hematology|March 19, 2026
Cord blood versus matched related donor transplantation in AML not in remission: role of pre-engraftment immune reactionsTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Pageof 10